Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades9,036
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions1
GSK
Media
GSK Company
Research
GSK Company
Timeline1
Share Price Information for Glaxosmithkline (GSK)
Last checked at -
Last checked at 
Intraday Glaxosmithkline Share Chart
Glaxosmithkline News
LONDON BRIEFING: Shell trims output view but refining margins climb
(Alliance News) - Shell says the Middle East conflict hit output in its Integrated Gas arm, though it sees "significantly higher" trading and optimisa...
GSK's Exdensur gets green light from Chinese regulator
(Sharecast News) - Drugmaker GSK said on Wednesday that China's National Medical Products Administration has approved Exdensur as an add‑on ther...
UK finalises US pharma deal granting tariff-free access for British medicines
* Agreement reached as part of a wider US-UK trade accord
Shionogi completes purchase of Pfizer stake in GSK's ViiV Healthcare
(Alliance News) - GSK PLC and Shionogi & Co Ltd on Wednesday said the replacement of Pfizer Inc's stake in the ViiV Healthcare Ltd joint venture with ...
LONDON MARKET OPEN: FTSE 100 higher as oil, mining stocks climb
(Alliance News) - Stock prices in London opened mixed on Monday, ahead of UK mortgage approvals data and as the US and Iran's contrasting statements o...
GSK shares rise on regulatory momentum for two drugs in China
(Alliance News) - GSK PLC on Monday reported regulatory momentum in China for its drugs Exdensur and bepirovirsen.
European Medicine Agency to review GSK's chronic hepatitis B treatment
(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted for review its investigational chronic hepatitis B treatment, bepi...
Follow the stocks
